In December, we welcomed 21 new analysts to Seeking Alpha. This article showcases their stock picks and investment strategies ...

Micron Technology has a bullish outlook as HBM3E and HBM4 power AI, FY2026 revenue near $74B, and $20B capex supply risk.

Explore the Crypto-Asset Reporting Framework (CARF), a global OECD initiative for tax transparency in crypto transactions ...

Halogen bonds were first proposed as an activating interaction in 2008, but this alternative type of organocatalysis was ...

Warren Buffett has spent decades repeating a deceptively simple warning: the first rule of investing is not to lose money, ...

Objectives Older adults can have difficulties understanding and recalling information prior to hospitalisation for elective treatment. Limited research exists regarding how older adults perceive the ...

When markets are soaring, it is easy to forget that stocks can fall 50% and stay there long enough to test anyone's nerve.

Background Inflammatory bowel disease (IBD) arises from complex interactions among diet, host and gut microbiome. Although diet influences intestinal inflammation, the microbial and metabolic pathways ...

In a world primarily focused on funding announcements, valuations and investor optics, the “big picture” of building a truly ...

Adjusted net income, a non-GAAP financial measure, for the fiscal second quarter 2026, was $0.1 million, or $0.00 per basic and diluted share. This compares to an adjusted net loss, a non-GAAP ...

Calumet, Inc. (NASDAQ: CLMT) (the "Company," "Calumet," "we," "our" or "us") announced today preliminary selected financial results for the year ended December 31, 2025.